| A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014) (NCT00322231) | Merck Sharp & Dohme LLC | 2006-05-01 |
| Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422) (NCT00367237) | Merck Sharp & Dohme LLC | 2006-05-01 |
| Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793) (NCT00709228) | Merck Sharp & Dohme LLC | 2006-05-01 |
| Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600) (NCT00723710) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) (NCT00312858) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) (NCT00851643) | Merck Sharp & Dohme LLC | 2006-04-01 |
| A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet (NCT00566267) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass (NCT00316212) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068) (NCT00289913) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) (NCT00325130) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED) (NCT00305604) | Merck Sharp & Dohme LLC | 2006-03-08 |
| Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3) (NCT00394589) | Merck Sharp & Dohme LLC | 2006-03-01 |
| MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040) (NCT00289848) | Merck Sharp & Dohme LLC | 2006-03-01 |
| V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) (NCT00109343) | Merck Sharp & Dohme LLC | 2006-03-01 |
| MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) (NCT00302471) | Merck Sharp & Dohme LLC | 2006-03-01 |
| Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690) (NCT00725205) | Merck Sharp & Dohme LLC | 2006-03-01 |
| Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) (NCT00548080) | Merck Sharp & Dohme LLC | 2006-03-01 |
| Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026) (NCT00474253) | Merck Sharp & Dohme LLC | 2006-02-10 |
| V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010) (NCT00258154) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015) (NCT00288431) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (NCT00727298) | Merck Sharp & Dohme LLC | 2006-02-01 |
| A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019) (NCT00293254) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED) (NCT00779285) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED) (NCT00724230) | Merck Sharp & Dohme LLC | 2006-02-01 |
| A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2) (NCT00293267) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED) (NCT00705666) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) (NCT00289900) | Merck Sharp & Dohme LLC | 2006-01-24 |
| The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071) (NCT00266799) | Merck Sharp & Dohme LLC | 2006-01-13 |
| Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001) (NCT00701103) | Merck Sharp & Dohme LLC | 2006-01-12 |
| A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956) (NCT00591409) | Merck Sharp & Dohme LLC | 2006-01-03 |
| A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED) (NCT00975052) | Merck Sharp & Dohme LLC | 2006-01-01 |
| Lipid Efficacy Study (0524B-022)(COMPLETED) (NCT00269217) | Merck Sharp & Dohme LLC | 2006-01-01 |
| Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) (NCT00724243) | Merck Sharp & Dohme LLC | 2006-01-01 |
| Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641) (NCT00726609) | Merck Sharp & Dohme LLC | 2006-01-01 |
| A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025) (NCT00251589) | Merck Sharp & Dohme LLC | 2006-01-01 |
| A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) (NCT00250432) | Merck Sharp & Dohme LLC | 2006-01-01 |
| Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029) (NCT00474617) | Merck Sharp & Dohme LLC | 2005-12-29 |
| A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Japanese Participants. Part A (P05957) (NCT00591786) | Merck Sharp & Dohme LLC | 2005-12-05 |
| A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048) (NCT00961857) | Merck Sharp & Dohme LLC | 2005-12-01 |
| A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005) (NCT00282763) | Merck Sharp & Dohme LLC | 2005-12-01 |
| A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250) (NCT00705289) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584) (NCT00736242) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001) (NCT00260039) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) (NCT00686790) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) (NCT00687544) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Upper GI Handling of Branded vs. Generic Alendronate (NCT00400530) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Lipid Efficacy/Tolerability Study (0524A-020) (NCT00269204) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025) (NCT00473694) | Merck Sharp & Dohme LLC | 2005-11-28 |
| Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960) (NCT00451217) | Merck Sharp & Dohme LLC | 2005-11-17 |
| Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931) (NCT00451100) | Merck Sharp & Dohme LLC | 2005-11-10 |
| Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934) (NCT00420680) | Merck Sharp & Dohme LLC | 2005-11-07 |
| A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) (NCT00246337) | Merck Sharp & Dohme LLC | 2005-11-01 |
| V710 First-In-Man (FIM) Study (V710-001) (NCT00303069) | Merck Sharp & Dohme LLC | 2005-11-01 |
| Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003) (NCT01011725) | Merck Sharp & Dohme LLC | 2005-11-01 |
| Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004) (NCT00245544) | Merck Sharp & Dohme LLC | 2005-11-01 |
| Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED) (NCT00274716) | Merck Sharp & Dohme LLC | 2005-11-01 |
| Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) (NCT00475215) | Merck Sharp & Dohme LLC | 2005-10-27 |
| Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) (NCT00298831) | Merck Sharp & Dohme LLC | 2005-10-27 |
| A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974) (NCT00552929) | Merck Sharp & Dohme LLC | 2005-10-04 |
| Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011) (NCT00496093) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED) (NCT00130832) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED) (NCT00230230) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671) (NCT00728494) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED) (NCT00157950) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261) (NCT00726557) | Merck Sharp & Dohme LLC | 2005-10-01 |
| Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED) (NCT00684567) | Merck Sharp & Dohme LLC | 2005-09-27 |
| A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971) (NCT00552617) | Merck Sharp & Dohme LLC | 2005-09-20 |
| Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672) (NCT00243230) | Merck Sharp & Dohme LLC | 2005-09-19 |
| A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011) (NCT00231816) | Merck Sharp & Dohme LLC | 2005-09-01 |
| An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) (NCT00130806) | Merck Sharp & Dohme LLC | 2005-09-01 |
| A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED) (NCT00131404) | Merck Sharp & Dohme LLC | 2005-09-01 |
| The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) (NCT00251641) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301) (NCT00704717) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285 (NCT00243568) | Merck Sharp & Dohme LLC | 2005-09-01 |
| An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) (NCT00127101) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED) (NCT00723632) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) (NCT00128115) | Merck Sharp & Dohme LLC | 2005-09-01 |
| A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009) (NCT00242476) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1)) (NCT00111813) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842) (NCT00844922) | Merck Sharp & Dohme LLC | 2005-09-01 |
| V930 First in Man (FIM) Study (V930-002)(COMPLETED) (NCT00250419) | Merck Sharp & Dohme LLC | 2005-09-01 |
| A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006) (NCT00296569) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Study to Treat Uveitis Associated Macular Edema (NCT00114062) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (NCT00139932) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED) (NCT00160251) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573) (NCT00132912) | Merck Sharp & Dohme LLC | 2005-08-30 |
| Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED) (NCT00727311) | Merck Sharp & Dohme LLC | 2005-08-01 |
| AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) (NCT00122343) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423) (NCT00724893) | Merck Sharp & Dohme LLC | 2005-08-01 |
| V260 Registration Study (V260-013)(COMPLETED) (NCT00166517) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors (NCT00106626) | Merck Sharp & Dohme LLC | 2005-08-01 |
| A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED) (NCT00130793) | Merck Sharp & Dohme LLC | 2005-08-01 |
| A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007) (NCT00231790) | Merck Sharp & Dohme LLC | 2005-08-01 |
| A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C (NCT00118768) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED) (NCT00254982) | Merck Sharp & Dohme LLC | 2005-08-01 |
| A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007) (NCT00907738) | Merck Sharp & Dohme LLC | 2005-08-01 |
| A Study in Pediatric Patients With Cystic Fibrosis Lung Disease (NCT00130182) | Merck Sharp & Dohme LLC | 2005-08-01 |
| A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema (NCT00135655) | Merck Sharp & Dohme LLC | 2005-08-01 |
| An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED) (NCT00131430) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED) (NCT00778869) | Merck Sharp & Dohme LLC | 2005-08-01 |